P2X7-dependent immune pathways in retinal diseases

Paul-Alexandre Déchelle-Marquet1, Xavier Guillonneau1, Florian Sennlaub1

  • 1Sorbonne University, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France.

Neuropharmacology
|November 13, 2022
PubMed

Insights

Adenosine triphosphate (ATP) acts as a danger signal, sensed by the P2X7 receptor. This review explores P2X7

Area of Science:

  • Ophthalmology
  • Immunology
  • Neuroscience

Background:

  • Adenosine triphosphate (ATP) is a crucial signaling molecule with neurotransmitter and danger signal functions.
  • The P2X7 receptor is a primary sensor for high ATP concentrations released by damaged cells.
  • P2X7 is expressed in the retina by microglia and infiltrating immune cells, particularly in diseases like age-related macular degeneration (AMD) and uveitis.

Purpose of the Study:

  • To review the role of the P2X7 receptor in the pathogenesis of ocular diseases.
  • To discuss the potential involvement of P2X7 in the development of age-related macular degeneration (AMD) and uveitis.

Main Methods:

  • Literature review of studies investigating P2X7 receptor function in ocular tissues.
  • Analysis of P2X7 expression patterns in retinal cells during disease states.
  • Examination of P2X7-mediated signaling pathways relevant to inflammation and cell death in the eye.

Main Results:

  • P2X7 activation is implicated in key pathological processes including phagocytosis, inflammasome activation (NLRP3), pro-inflammatory mediator release, and cell death.
  • The P2X7 receptor plays a significant role in the inflammatory response within the retina.
  • Evidence suggests P2X7 involvement in the progression of retinal degenerative and inflammatory diseases.

Conclusions:

  • The P2X7 receptor is a critical mediator in the inflammatory and degenerative processes observed in AMD and uveitis.
  • Targeting the P2X7 receptor may offer a therapeutic strategy for managing these debilitating eye conditions.